GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hunan Nucien Pharmaceutical Co Ltd (SHSE:688189) » Definitions » Ending Cash Position

Hunan Nucien Pharmaceutical Co (SHSE:688189) Ending Cash Position : ¥400.4 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Hunan Nucien Pharmaceutical Co Ending Cash Position?

Hunan Nucien Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥400.4 Mil.

Hunan Nucien Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2024 (¥388.5 Mil) to Dec. 2024 (¥490.3 Mil) but then declined from Dec. 2024 (¥490.3 Mil) to Mar. 2025 (¥400.4 Mil).

Hunan Nucien Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2022 (¥713.5 Mil) to Dec. 2023 (¥561.7 Mil) and declined from Dec. 2023 (¥561.7 Mil) to Dec. 2024 (¥490.3 Mil).

Hunan Nucien Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Hunan Nucien Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Nucien Pharmaceutical Co Ending Cash Position Chart

Hunan Nucien Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 299.35 730.67 713.47 561.73 490.27

Hunan Nucien Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 543.31 528.44 388.51 490.27 400.37

Hunan Nucien Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hunan Nucien Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=561.729+-71.459
=490.3

Hunan Nucien Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=490.271+-89.905
=400.4

Hunan Nucien Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hunan Nucien Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Nucien Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hunan Nucien Pharmaceutical Co Ltd (SHSE:688189) » Definitions » Ending Cash Position
Comparable Companies
SZSE:002898 SHSE:600200 SHSE:688163 SZSE:300966 SHSE:605177 SHSE:688265 SHSE:688670 SHSE:688426 SZSE:000518 SZSE:002873 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 1 Kangli Road, Liuyang Economic and Technological Development Zone, Hunan Province, Changsha, CHN, 510100
Website
http://www.nucien.com
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields.

Hunan Nucien Pharmaceutical Co Headlines

No Headlines